Fresenius Medical Care Expands Dialysis Therapy Services in Mexico

Fresenius Medical Care AG, a leading healthcare provider, has partnered with the Coordination of National Institutes of Health and Specialty Hospital in Mexico to expand its dialysis therapy services.

• The partnership aims to extend access to High-Volume Hemodiafiltration (HDF) dialysis therapy in seven out of ten centers.
• This move is part of Fresenius Medical Care’s commitment to expanding its innovative therapy to all markets where it is not already present, including the United States.

Market Reaction

The company’s efforts to improve access to life-saving treatments have been well-received by investors, with its stock price experiencing a moderate increase.

• Fresenius Medical Care’s stock price has risen in line with the overall market trend.
• The German stock market, including the DAX, has shown a positive trend.

Key Details

• Fresenius Medical Care AG is a leading healthcare provider.
• The company has partnered with the Coordination of National Institutes of Health and Specialty Hospital in Mexico.
• The partnership aims to expand access to High-Volume Hemodiafiltration (HDF) dialysis therapy in seven out of ten centers.